Cancerous stem cells can arise from pediatric brain tumors

Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83. doi: 10.1073/pnas.2036535100. Epub 2003 Nov 26.

Abstract

Pediatric brain tumors are significant causes of morbidity and mortality. It has been hypothesized that they derive from self-renewing multipotent neural stem cells. Here, we tested whether different pediatric brain tumors, including medulloblastomas and gliomas, contain cells with properties similar to neural stem cells. We find that tumor-derived progenitors form neurospheres that can be passaged at clonal density and are able to self-renew. Under conditions promoting differentiation, individual cells are multipotent, giving rise to both neurons and glia, in proportions that reflect the tumor of origin. Unlike normal neural stem cells, however, tumor-derived progenitors have an unusual capacity to proliferate and sometimes differentiate into abnormal cells with multiple differentiation markers. Gene expression analysis reveals that both whole tumors and tumor-derived neurospheres express many genes characteristic of neural and other stem cells, including CD133, Sox2, musashi-1, bmi-1, maternal embryonic leucine zipper kinase, and phosphoserine phosphatase, with variation from tumor to tumor. After grafting to neonatal rat brains, tumor-derived neurosphere cells migrate, produce neurons and glia, and continue to proliferate for more than 4 weeks. The results show that pediatric brain tumors contain neural stem-like cells with altered characteristics that may contribute to tumorigenesis. This finding may have important implications for treatment by means of specific targeting of stem-like cells within brain tumors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AC133 Antigen
  • Animals
  • Antigens, CD
  • Brain / pathology
  • Brain Neoplasms / pathology*
  • Bromodeoxyuridine / pharmacology
  • Cell Differentiation
  • Child
  • Coloring Agents / pharmacology
  • DNA-Binding Proteins / biosynthesis
  • Gene Expression Regulation, Neoplastic
  • Glycoproteins / biosynthesis
  • HMGB Proteins
  • Humans
  • Immunohistochemistry
  • Infant
  • Neoplasm Transplantation
  • Nerve Tissue Proteins / biosynthesis
  • Neuroglia / pathology*
  • Neurons / pathology*
  • Nuclear Proteins / biosynthesis
  • Peptides
  • Phosphoric Monoester Hydrolases / biosynthesis
  • RNA-Binding Proteins / biosynthesis
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • SOXB1 Transcription Factors
  • Stem Cells / pathology*
  • Transcription Factors

Substances

  • AC133 Antigen
  • Antigens, CD
  • Coloring Agents
  • DNA-Binding Proteins
  • Glycoproteins
  • HMGB Proteins
  • MSI1 protein, human
  • Msi1 protein, rat
  • Nerve Tissue Proteins
  • Nuclear Proteins
  • PROM1 protein, human
  • Peptides
  • Prom1 protein, rat
  • RNA-Binding Proteins
  • SOX2 protein, human
  • SOXB1 Transcription Factors
  • Sox2 protein, rat
  • Transcription Factors
  • Phosphoric Monoester Hydrolases
  • phosphoserine phosphatase
  • Bromodeoxyuridine